Occam Places Allison August as CMO at Comanche Bio
Comanche Biopharma is a preclinical biopharmaceutical company developing a novel siRNA therapy for the treatment of preeclampsia. Investors include GV, F-Prime, and Population Health Partners. The company has appointed Allison August, M.D. as Chief Medical Officer. Dr. August, an obstetrician-gynecologist, brings more than 25 years of clinical experience to her position at Comanche Biopharma.
August joins Comanche Biopharma from Moderna, where she was Vice President of Clinical Development, Infectious Diseases, and spent over five years in various roles with increasing responsibility for the development of mRNA-based vaccines and the first mRNA-encoded monoclonal antibody.
Before moving to the biopharma industry, August was an academic and private practice obstetrician-gynecologist. Her academic career included faculty positions at the Brown University Medical School and adjunct faculty at Harvard Medical School affiliated hospitals. Dr. August holds a B.A. in the History of Religion from Bryn Mawr College and an M.D. from the University of Chicago
Recent Placements
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.